TGFB1 and Myocardial fibrosis: In a recent 2025 study, serum transforming growth factor-beta 1 (TGF-β1) levels correlated with CMR-detected myocardial fibrosis in patients with AS, suggesting potential for integrating blood biomarkers with advanced imaging to quantify ventricular remodeling [77].